Bumper Offer - Urjas oil Just @ Rs. 1
Terbicrat is a commercial drug that is prescribed in the form of Cream. Primarily, it is used for the treatment of Fungal Infections, Nail Fungus. Secondary and off-label uses of Terbicrat have also been mentioned below.
The optimal dosage of Terbicrat is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Terbicrat include Abdominal Pain, Headache, Flatulence. Some other side effects of Terbicrat have been listed ahead. These side effects of Terbicrat are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Terbicrat is Safe for pregnant women and Severe for women who are breastfeeding. Warnings related to Terbicrat's effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Terbicrat have been discussed in the sections ahead.
Additionally, Terbicrat may also adversely react with other medicines. See below for a complete list.
You should also be aware that Terbicrat is not safe while driving, and is not addiction.
Terbicrat is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Terbicrat is used -
Severe
Moderate
Mild
Common
Is the use of Terbicrat safe for pregnant women?
Terbicrat is safe for pregnant women.
Is the use of Terbicrat safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Terbicrat. So it is adviced to consult the doctor before using it.
What is the effect of Terbicrat on the Kidneys?
There may be some adverse effects on kidney after taking Terbicrat. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Terbicrat on the Liver?
Terbicrat may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Terbicrat on the Heart?
You can take Terbicrat without any fear of damage to the heart.
Terbicrat should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Terbicrat unless your doctor advises you to do so -
Is this Terbicrat habit forming or addictive?
Terbicrat does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Terbicrat can make you feel drowsy.
Is it safe?
Yes, Terbicrat is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Terbicrat in mental disorders is not effective.
Interaction between Food and Terbicrat
It is safe to take Terbicrat with food.
Interaction between Alcohol and Terbicrat
Due to lack of research, there is no information about the side effects of taking Terbicrat with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
